GlassScriptPhysician profile
Rainbow A Tarumoto
NPI 1073002440
$1,228.07
in general payments reported to CMS, 2019-2025
14 companies · $305 in 2025
The $305 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $118 · 2022: $345 · 2023: $144 · 2024: $315 · 2025: $305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $765.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $765.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $330.93 | 2022-2024 | |
| Otsuka America Pharmaceutical, INC. | $123.06 | 2024 | Rexulti |
| Neurocrine Biosciences, INC. | $119.34 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $117.80 | 2025 | Cobenfy |
| Solventum Corporation | $113.84 | 2024-2025 | V.A.C.Instill |
| Abbvie INC. | $105.74 | 2021-2022 | |
| Axsome Therapeutics, INC. | $101.84 | 2024 | Auvelity |
| Urgo Medical North America, LLC | $56.37 | 2023-2025 | Urgok2, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Kci USA, INC. | $41.54 | 2021-2022 | |
| Activ Surgical, INC. | $27.20 | 2022 | |
| Ethicon US, LLC | $26.03 | 2022 | |
| Teleflex LLC | $25.23 | 2021 | |
| Alexion Pharmaceuticals, INC. | $25.10 | 2022 | |
| W. L. Gore & Associates, INC. | $14.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rainbow Tarumoto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.